← Browse by Condition
Medical Condition
alopecia areata
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2
NCT06573593
Recruiting
Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
Enrollment
150 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT06747611 Phase 2
Recruiting
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Enrollment
40 pts
Location
United States
Sponsor
University of Minnesota
NCT06104839 Phase 2
Recruiting
Safety and Efficacy of Oral NXC-736 in Adult Participants with Moderate and Severe Alopecia Areata
Enrollment
96 pts
Location
South Korea
Sponsor
NEXTGEN Bioscience
NCT07250997
Recruiting
PALLAS Laser for Skin Diseases
Enrollment
50 pts
Location
Hungary
Sponsor
Szeged University
NCT05398809 Phase 2
Recruiting
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Enrollment
70 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06562270
Recruiting
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Enrollment
1,500 pts
Location
United States
Sponsor
CorEvitas